# Another study shows broad positive outcomes for Afrezza

**URL:** <https://forum.fudiabetes.org/t/another-study-shows-broad-positive-outcomes-for-afrezza/5207>\
**Category:** Afrezza\
**Created:** [October 13, 2018, 6:37am UTC](https://forum.fudiabetes.org/t/another-study-shows-broad-positive-outcomes-for-afrezza/5207 "2018-10-13T06:37:04Z")\
**Posts on this page:** 4\
**Page:** 1

<div class="post-metadata">

**Author:** ![Michel](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/michel/32/387_2.png) [@Michel](https://forum.fudiabetes.org/u/Michel)\
**Post date:** [October 13, 2018, 6:37am UTC](https://forum.fudiabetes.org/t/another-study-shows-broad-positive-outcomes-for-afrezza/5207/1 "2018-10-13T06:37:04Z")

</div>

This new study shows a broad set of positive outcomes for Afrezza patients:

Healio: Inhaled insulin improves glucose control in type 1 diabetes.

> **[Diabetes News](https://www.healio.com/news/endocrinology/diabetes)**
>
> Find the latest Diabetes news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.

The small study (26 subjects) randomly assigned patient to an inhaled vs injection regimen, thereby removing self-selection bias.

Positive outcomes:

> The researchers observed more time in range, lower glucose standard deviation and less time in hyperglycemia in the inhaled insulin-compliant group

> Postprandial glucose levels differed the most between the two groups 60 to 90 minutes after a meal, with postprandial glucose levels increasing in the insulin aspart group during the first hour after a meal, and dropping to their lowest point for the inhaled insulin group,

---

<div class="post-metadata">

**Author:** ![MM2](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/mm2/32/3032_2.png) [@MM2](https://forum.fudiabetes.org/u/MM2)\
**Post date:** [October 15, 2018, 1:33am UTC](https://forum.fudiabetes.org/t/another-study-shows-broad-positive-outcomes-for-afrezza/5207/2 "2018-10-15T01:33:41Z")

</div>

I have had good success with Afrezza, but due to cost and no coverage by my insurance, I don’t use it regularly. But would use more often if cost was reasonable, relative to what I pay for Novolog in pump.

---

<div class="post-metadata">

**Author:** ![Sam](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/sam/32/10595_2.png) [@Sam](https://forum.fudiabetes.org/u/Sam)\
**Post date:** [October 15, 2018, 5:36am UTC](https://forum.fudiabetes.org/t/another-study-shows-broad-positive-outcomes-for-afrezza/5207/3 "2018-10-15T05:36:32Z")

</div>

Have you looked into all the discounts available and exhausted the avenues for prior auth with your insurance?

---

<div class="post-metadata">

**Author:** ![MM2](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/mm2/32/3032_2.png) [@MM2](https://forum.fudiabetes.org/u/MM2)\
**Post date:** [October 15, 2018, 3:17pm UTC](https://forum.fudiabetes.org/t/another-study-shows-broad-positive-outcomes-for-afrezza/5207/4 "2018-10-15T15:17:23Z")

</div>

Yes, I use the discount card, and lowest price found at Costco. It has steadily risen over the past years.